UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.092

Sortiert nach

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

The Lancet (British edition), 1998-07, Vol.352 (9123), p.179-184

1998

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the efficacy of candesartan and losartan: a meta-analysis of trials in the treatment of hypertension

Journal of human hypertension, 2010-08, Vol.24 (8), p.525-531

2010

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?

Journal of human hypertension, 2005-05, Vol.19 (5), p.331-339

2005

Link zum Volltext

Verfügbarkeit prüfen

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

The Lancet (British edition), 2005-09, Vol.366 (9489), p.895-906

2005

Link zum Volltext

Verfügbarkeit prüfen

Integrated approaches to management of hypertension: Promoting treatment acceptance

The American heart journal, 1999-09, Vol.138 (3), p.S252-S255

McInnes, Gordon T.

1999

Link zum Volltext

Verfügbarkeit prüfen

Microalbuminuria in subjects with hypertension attending specialist blood pressure clinics

Journal of human hypertension, 2016-09, Vol.30 (9), p.527-533

2016

Link zum Volltext

Verfügbarkeit prüfen

Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study

European journal of neurology, 2005-07, Vol.12 (7), p.493-498

2005

Link zum Volltext

Verfügbarkeit prüfen

Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) study

Journal of hypertension, 1999-07, Vol.17 (7), p.1041-1045

1999

Link zum Volltext

Verfügbarkeit prüfen

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

The Lancet (British edition), 2005-09, Vol.366 (9489), p.907-913

2005

Link zum Volltext

Verfügbarkeit prüfen

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)

Diabetes care, 2005-05, Vol.28 (5), p.1151-1157

2005

Link zum Volltext

Verfügbarkeit prüfen

Do we need more long-term outcome trials for the treatment of hypertension?

The Journal of the Royal College of Physicians of Edinburgh, 2011-03, Vol.41 (1), p.30-37

2011

Link zum Volltext

Verfügbarkeit prüfen

The effect of antihypertensive agents in people at high risk of cardiovascular disease and diabetes: a view through smoke and mirrors

Journal of human hypertension, 2011-06, Vol.25 (6), p.343-345

McInnes, G T

2011

Link zum Volltext

Verfügbarkeit prüfen

Antihypertensive drugs in combination: additive or greater than additive?

Journal of human hypertension, 2007-12, Vol.21 (12), p.914-916

McInnes, G T

2007

Link zum Volltext

Verfügbarkeit prüfen

ALLHAT: a saga of missed opportunities

Journal of human hypertension, 2003-06, Vol.17 (6), p.373-377

McInnes, G T

2003

Link zum Volltext

Verfügbarkeit prüfen

Lessons from the recent trials on hypertension treatment

Nephrology, dialysis, transplantation, 2001-01, Vol.16 (suppl-6), p.43-45

MCINNES, G. T

2001

Link zum Volltext

Verfügbarkeit prüfen

Systolic Hypertension as a Cardiovascular Risk Factor

Blood pressure, 2002, Vol.11 (3), p.134-143

McInnes, G. T.

2002

Link zum Volltext

Verfügbarkeit prüfen

Association of renin-angiotensin system gene polymorphisms with antihypertensive responses to angiotensin-converting enzyme inhibition or angiotensin receptor blockade

Journal of human hypertension, 2005-12, Vol.19 (12), p.971-974

2005

Link zum Volltext

Verfügbarkeit prüfen

Renin inhibition: the holy grail of renin-angiotensin system blockade?

Journal of human hypertension, 2007-10, Vol.21 (10), p.766-769

McInnes, G T

2007

Link zum Volltext

Verfügbarkeit prüfen

Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol

Journal of human hypertension, 2001-08, Vol.15 Suppl 1 (S1), p.S11-S12

2001

Link zum Volltext

Verfügbarkeit prüfen

Why not prescribe the best drugs for hypertension now?

Journal of human hypertension, 2003-07, Vol.17 (7), p.505-511

2003

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients

Journal of human hypertension, 2000-04, Vol.14 (4), p.263-269

2000

Link zum Volltext

Verfügbarkeit prüfen

The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population

Journal of human hypertension, 1997-09, Vol.11 Suppl 2, p.S75

1997

Link zum Volltext

Verfügbarkeit prüfen

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial

Drugs (Basel), 2004, Vol.64 (Supplement 2), p.43-60

2004

Link zum Volltext

Verfügbarkeit prüfen

Cancer risk of hypertensive patients taking calcium antagonists

Journal of hypertension, 1998-01, Vol.16 (1), p.119-124

1998

Link zum Volltext

Verfügbarkeit prüfen

Clinical Advantage of Valsartan

Cardiology, 1999-01, Vol.91 (1), p.14-18

McInnes, Gordon T.

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.092

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(990)
Mit Volltextzugriff
(951)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.088)
Japanisch
(109)
Französisch
(6)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Canadian Journal Of Chemistry
(65)
Annals Of The Rheumatic Diseases
(59)
British Journal Of Clinical Pharmacology
(30)
Journal Of Hypertension
(30)
Journal Of Human Hypertension
(27)
The Lancet
(22)
Bmj
(20)
British Medical Journal
(20)
Plos One
(17)
Rheumatology
(15)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

Comparison of the efficacy of candesartan and losartan: a meta-analysis of trials in the treatment of hypertension

Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?

Integrated approaches to management of hypertension: Promoting treatment acceptance

Microalbuminuria in subjects with hypertension attending specialist blood pressure clinics

Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study

Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) study

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)

Do we need more long-term outcome trials for the treatment of hypertension?

The effect of antihypertensive agents in people at high risk of cardiovascular disease and diabetes: a view through smoke and mirrors

Antihypertensive drugs in combination: additive or greater than additive?

ALLHAT: a saga of missed opportunities

Lessons from the recent trials on hypertension treatment

Systolic Hypertension as a Cardiovascular Risk Factor

Association of renin-angiotensin system gene polymorphisms with antihypertensive responses to angiotensin-converting enzyme inhibition or angiotensin receptor blockade

Renin inhibition: the holy grail of renin-angiotensin system blockade?

Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol

Why not prescribe the best drugs for hypertension now?

Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients

The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial

Cancer risk of hypertensive patients taking calcium antagonists

Clinical Advantage of Valsartan

Suchergebnisse filtern